Skip to content

Public FDA record

Z-0613-03: REMEL CXM 30 Cefuroxime 30 mcg, Antimicrobial Susceptibility Test Disk, 50 disks to a cartridge, 5 cartri

Recall record Z-0613-03 for Remel, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0613-03
Company in FDA record
Remel, Inc.
FDA classification date
Mar 6, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Packages of Cefuroxime susceptibility disks erroneously contained Cefaclor susceptibility disks.

Source facts

Action
Recall letters dated 12/5/02 were issued requesting destruction of the product by the customer.
Initiated
2002-12-05
Root cause
Other
Terminated
2003-03-31
Distribution
The product was distributed nationwide to 62 medical facilities including 3 military and 4 government accounts. No foreign accounts were reported.
Recall number
Z-0613-03
Recall status
Terminated
CDRH record ID
25822
FDA classified
2003-03-06
Recall event number
25250

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗